Recent research reveals that patients treated with enzalutamide had prolonged time to first skeletal-related event, pain progression, and health-related QoL deterioration compared with placebo.
Researchers continue to search for a molecular pathway or biomarker to improve treatment options for patients with sorafenib-refractory HCC.
Narrow band imaging may improve visualization of polyps during colonoscopy, but there are still questions as to whether it is a truly useful screening tool.
Helicobacter Pylori infection is associated with many ailments, including gastric cancer.
Administering proton pump inhibitors concomitantly with erlotinib can cause harmful drug-to-drug interactions.
There is little research on whether adjuvant chemo is beneficial for patients with periampullary carcinoma, so treating the disease can be a challenge.
The start of the “sun-worshipping season” is a good time to review the basics of basal cell and squamous cell carcinomas.
There is no solid data that proves a link between IBS and CRC, but clinicians should be aware of symptoms that may complicate differential diagnosis.
Ampullary adenocarcinoma is a rare disease with a lack of treatment data, therefore, managing the disease can be a challenge.
Diagnosing and treating a cancer of unknown origin can be a challenging and daunting task for clinicians.
